Fate Therapeutics Inc (FATE)

[jondoeuk]

(OT): InnDura Therapeutics is a preclinical stage company, with a platform based on licensed technologies developed by Dr. Rizwan Romee at the Dana-Farber Cancer Institute and Professor Jianzhu Chen at MIT that focuses on EVE16 engineering of NK cells. EVE16 is a non-CAR approach that provides enhanced cell killing with greatly reduced exhaustion and fratricide. The EVE16 technology can also be applied to T-cells and other forms of cell therapy https://www.inndura.com/